Krilogy Financial’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-205,441
Closed -$5.16M 951
2025
Q3
$5.16M Buy
205,441
+24,505
+14% +$616K 0.19% 83
2025
Q2
$4.56M Buy
180,936
+51,276
+40% +$1.29M 0.26% 79
2025
Q1
$3.26M Sell
129,660
-10,817
-8% -$272K 0.21% 96
2024
Q4
$3.52M Buy
140,477
+6,178
+5% +$155K 0.23% 91
2024
Q3
$3.37M Sell
134,299
-26,489
-16% -$661K 0.23% 96
2024
Q2
$4M Buy
160,788
+736
+0.5% +$18.2K 0.29% 74
2024
Q1
$3.97M Buy
160,052
+9,731
+6% +$241K 0.3% 71
2023
Q4
$3.72M Buy
150,321
+2,817
+2% +$69K 0.32% 75
2023
Q3
$3.59M Buy
147,504
+208
+0.1% +$5.07K 0.33% 71
2023
Q2
$3.59M Buy
147,296
+825
+0.6% +$20.2K 0.32% 71
2023
Q1
$3.59M Buy
146,471
+88,449
+152% +$2.16M 0.3% 73
2022
Q4
$1.41M Sell
58,022
-67,230
-54% -$1.63M 0.13% 124
2022
Q3
$3.02M Buy
125,252
+404
+0.3% +$9.97K 0.36% 51
2022
Q2
$3.08M Buy
124,848
+38,085
+44% +$948K 0.36% 51
2022
Q1
$2.19M Sell
86,763
-62,518
-42% -$1.61M 0.22% 66
2021
Q4
$3.94M Buy
149,281
+630
+0.4% +$16.7K 0.4% 48
2021
Q3
$3.99M Buy
148,651
+3,442
+2% +$92.8K 0.4% 45
2021
Q2
$3.92M Buy
145,209
+16,638
+13% +$449K 0.39% 45
2021
Q1
$3.45M Buy
128,571
+31,371
+32% +$849K 0.36% 47
2020
Q4
$2.66M Buy
97,200
+889
+0.9% +$24.2K 0.32% 52
2020
Q3
$2.61M Sell
96,311
-21,425
-18% -$582K 0.36% 48
2020
Q2
$3.18M Buy
117,736
+52,775
+81% +$1.39M 0.49% 33
2020
Q1
$1.62M Sell
64,961
-50,892
-44% -$1.31M 0.31% 49
2019
Q4
$3M Sell
115,853
-1,006
-0.9% -$26K 0.49% 39
2019
Q3
$3.02M Sell
116,859
-1,745
-1% -$44.9K 0.55% 38
2019
Q2
$3.04M Buy
118,604
+12,515
+12% +$313K 0.58% 32
2019
Q1
$2.64M Buy
+106,089
New +$2.58M 0.56% 34

Other funds holding IBDQ

Krilogy Financial's IBDQ Position: Q4 2025 in Review

Krilogy Financial sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 205,441 shares — an estimated $5.16M sold.

Krilogy Financial first reported a position in IBDQ in Q1 2019 and held it in 27 quarters. The position peaked at $5.16M in Q3 2025. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

  • Krilogy Financial reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
  • Krilogy Financial sold 205,441 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $5.16M.
  • Krilogy Financial first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q1 2019 and held it in 27 quarters.
  • Krilogy Financial's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $5.16M in Q3 2025.
  • 3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on Krilogy Financial's 13F filing for Q4 2025, filed 27 Jan 2026.